Publication | Closed Access

Comparison of imatinib, nilotinib and silymarin in the treatment of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis

FibrosisHepatologyMedicineLiver PhysiologyPathologyToxicologyPharmacotherapyHepatotoxicityLiver DiseaseHepatology FibrosisPharmacologyDrug-induced Liver InjuryOxidative Stress